REPLIGEN CORP RGEN

Latest FY: 2025 Healthcare Medical Instruments & Supplies
Market Price $166.87
Market Cap $9.45B
P/E Ratio 194.03
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑16.4% YoY
$738.26M
3-Yr CAGR: -2.7%
Net Income ↑291.6% YoY
$48.89M
Net Margin: 6.6%
Free Cash Flow ↓-37.3% YoY
$93.90M
FCF Yield: 0.99%
EPS (Diluted) ↑287.0% YoY
$0.86
Basic: $0.87
Return on Equity Efficiency
2.3%
ROA: 120.1%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (RGEN)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $104.5M $57.4M $11.7M $0.34 $7.5M $3.2M
FY 2017 $141.2M +35.1% $74.2M $28.4M +142.7% $0.72 +111.8% $17.5M $12.0M +275.4%
FY 2018 $194.0M +37.4% $107.5M $16.6M -41.4% $0.37 -48.6% $32.8M $22.1M +84.5%
FY 2019 $270.2M +39.3% $151.1M $21.4M +28.8% $0.44 +18.9% $67.2M $48.7M +120.1%
FY 2020 $366.3M +35.5% $209.6M $59.9M +179.9% $1.11 +152.3% $62.6M $40.2M -17.5%
FY 2021 $670.5M +83.1% $391.3M $128.3M +114.1% $2.24 +101.8% $119.0M $51.9M +29.3%
FY 2022 $801.5M +19.5% $455.7M $186.0M +45.0% $3.24 +44.6% $172.1M $87.2M +68.0%
FY 2023 $632.4M -21.1% $284.8M $35.6M -80.9% $0.63 -80.6% $113.9M $77.7M -10.9%
FY 2024 $634.4M +0.3% $274.6M $-25.5M -171.7% $-0.46 -173.0% $175.4M $149.7M +92.7%
FY 2025 $738.3M +16.4% $386.2M $48.9M +291.6% $0.86 +287.0% $117.4M $93.9M -37.3%
$

Valuation

Market Price $166.87
Market Cap $9.45B
Enterprise Value $9.43B
P/E Ratio 194.03
P/B Ratio 4.47
FCF Yield 0.99%
Dividend Yield N/A
Shares Outstanding 56,407,700
%

Profitability & Margins

Gross Margin 52.32%
Operating Margin 7.47%
Net Margin 6.62%
Return on Equity (ROE) 2.32%
Return on Assets (ROA) 120.10%
Asset Turnover 18.13x
Revenue 3-Yr CAGR -2.70%
🛡️

Financial Health & Liquidity

Current Ratio 0.51
Cash Ratio 7.15
Debt / Equity 0.257
Debt / Assets 13.318
Cash & Equivalents $566.02M
Total Debt $542.21M
Book Value / Share $37.34
💧

Cash Flow Efficiency

Operating Cash Flow $117.42M
Capital Expenditures (CapEx) $23.52M
Free Cash Flow $93.90M
OCF / Revenue 15.90%
FCF / Revenue 12.72%
FCF 3-Yr CAGR 2.48%
🏷️

Per Share Metrics

EPS (Diluted) $0.86
EPS (Basic) $0.87
Dividends / Share N/A
Book Value / Share $37.34
EPS YoY Growth 286.96%
🏛️

Balance Sheet (FY 2025)

Total Assets $40.71M
Total Liabilities $79.21M
Stockholders' Equity $2.11B
Current Assets $40.71M
Current Liabilities $79.21M